TrialClinical cancer research : an official journal of the American Association for Cancer Research2014

Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia.

Marina Y Konopleva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.